Broad‐Spectrum Antiviral Agents against SARS‐CoV‐2 Variants Inhibit the Conserved Viral Protein Nsp1–RNA Interaction
Open Access
- 17 October 2024
- journal article
- research article
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 63 (47) , e202405472
Abstract
The ongoing global threats posed by COVID‐19 pandemic, catalyzed by SARS‐CoV‐2, underscores the pressing need for effective antiviral strategies. The viral non‐structural protein 1 (Nsp1) significantly influences pathogenicity by impeding host protein expression and enhancing viral RNA translation through its interaction with the stem‐loop 1 (SL1) in the 5′ untranslated region (UTR). We have developed a novel dual‐luciferase reporter assay, designed to investigate the critical Nsp1–SL1 interaction, and identified P23E02 as a potential inhibitor. Our investigation, combining molecular docking studies and alanine mutagenesis, has unveiled that P23E02 disrupts Nsp1–40S ribosomal subunit interaction, liberating translational inhibition and empowering host antiviral responses. P23E02 exhibits antiviral efficacy against various sarbecoviruses, making it a promising candidate for combatting COVID‐19 and related diseases. This study underscores the therapeutic potential of targeting the Nsp1/SL1 axis and lays the foundation for innovative antiviral interventions, ultimately fortifying global preparedness against future viral threats.Keywords
Funding Information
- National Research Foundation of Korea (RS-2024-00438764, 2022M3A9J1081343, 2023M3A9G6057281, RS-2023-00273284)
This publication has 37 references indexed in Scilit:
- Structural insights into the activity regulation of full-length non-structural protein 1 from SARS-CoV-2Structure, 2023
- SARS‐CoV‐2 Non-structural protein 1(NSP1) mutation virulence and natural selection: Evolutionary trends in the six continentsVirus Research, 2022
- The N-terminal domain of SARS-CoV-2 nsp1 plays key roles in suppression of cellular gene expression and preservation of viral gene expressionCell Reports, 2021
- Nonstructural Protein 1 of SARS-CoV-2 Is a Potent Pathogenicity Factor Redirecting Host Protein Synthesis Machinery toward Viral RNAMolecular Cell, 2020
- Structure of the SARS-CoV-2 Nsp1/5′-Untranslated Region Complex and Implications for Potential Therapeutic Targets, a Vaccine, and VirulenceThe Journal of Physical Chemistry Letters, 2020
- SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host DefensesCell, 2020
- Evasion of Type I Interferon by SARS-CoV-2Cell Reports, 2020
- Comparative analysis of antiviral efficacy of FDA‐approved drugs against SARS‐CoV‐2 in human lung cellsJournal of Medical Virology, 2020
- Privileged Structures: Efficient Chemical “Navigators” toward Unexplored Biologically Relevant Chemical SpacesJournal of the American Chemical Society, 2014
- Construction of a Polyheterocyclic Benzopyran Library with Diverse Core Skeletons through Diversity-Oriented Synthesis PathwayJournal of Combinatorial Chemistry, 2010